SOFTBANK TO INVEST $900 MILLION IN US-BASED PACIFIC BIOSCIENCES OF CALIFORNIA

Highlights

• SoftBank Group has decided to invest $900 million in a US developer of equipment for genetic analysis

• This investment comes as billionaire Masayoshi Son’s SoftBank Group is looking to diversify its portfolio and mainly US listed companies

• Christian Henry, President and CEO of Pacific Biosciences said this investment enables us to further accelerate our growth strategies